Aspergillus

• 

  Subject Areas on Research

  • Advances against aspergillosis (September 9-11, 2004, San Francisco, California). 
  • An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome. 
  • Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. 
  • Aspergillus DNA contamination in blood collection tubes. 
  • Aspergillus infections in transplant and non-transplant surgical patients. 
  • Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. 
  • Calmodulin mediated activation of acetyl-CoA carboxylase during aflatoxin production by Aspergillus parasiticus. 
  • Cell biology. A fungal Achilles' heel. 
  • Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. 
  • Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. 
  • Combination antifungals: an update. 
  • DNA sequence characterization and molecular evolution of MAT1 and MAT2 mating-type loci of the self-compatible ascomycete mold Neosartorya fischeri. 
  • Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. 
  • Diagnostic accuracy of histopathologic and cytopathologic examination of Aspergillus species. 
  • Effect of sulphanilamide on citric acid production by Aspergillus niger. 
  • Emergence of the Molds Other than Aspergillus in Immunocompromised Patients. 
  • Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. 
  • Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. 
  • Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. 
  • Identification of fungi associated with municipal compost using DNA-based techniques. 
  • In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. 
  • Inflammatory cytokine gene expression in THP-1 cells exposed to Stachybotrys chartarum and Aspergillus versicolor. 
  • Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. 
  • Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity). 
  • Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. 
  • Isolation and insecticidal activity of mellamide from Aspergillus melleus. 
  • Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. 
  • Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens. 
  • Mitotic intragenic recombination as a consequence of heteroduplex formation in Aspergillus nidulans. 
  • Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. 
  • New findings and unique aspects in pediatric aspergillosis. 
  • Newer combination antifungal therapies for invasive aspergillosis. 
  • Nuances of new anti-Aspergillus antifungals. 
  • Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. 
  • Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. 
  • Pediatric aspergillosis: disease and treatment differences in children. 
  • Phylogenomic analysis of non-ribosomal peptide synthetases in the genus Aspergillus. 
  • Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. 
  • Potential Microbiological Effects of Higher Dosing of Echinocandins. 
  • Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. 
  • Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. 
  • Purification of alpha-sarcin and an antifungal protein from Aspergillus giganteus by blue sepharose CL-6B affinity chromatography. 
  • Putative calmodulin-binding domains in aflatoxin biosynthesis-regulatory proteins. 
  • Recent advances in antifungal pharmacotherapy for invasive fungal infections. 
  • Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia. 
  • Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan". 
  • Requirement of Ca2+ for aflatoxin production: inhibitory effect of Ca2+ channel blockers on aflatoxin production by Aspergillus parasiticus NRRL 2999. 
  • Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children. 
  • Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination. 
  • The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. 
  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. 
• 

  Keywords of People

  • Juvvadi, Praveen Rao, Assistant Professor in Pediatrics, Pediatrics, Infectious Diseases
  • Steinbach, William J., Professor of Pediatrics, Duke Innovation & Entrepreneurship